Chemokinostatin-3

General Information


DRACP ID  DRACP02510

Peptide Name   Chemokinostatin-3

Sequence  NGKKACLNPASPMVQKIIEKIL

Sequence Length  22

UniProt ID  P19876 

PubChem CID  Not available

Origin  Homo sapiens (CXCL3/Gro-γ)

Type  Native peptide

Classification

  

Active ACP Cancer targeted peptides Antiangiogenic



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  CXCR

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02510

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C106H187N29O29S2

Absent amino acids  DFHRTWY

Common amino acids  K

Mass  277072

Pl  10.34

Basic residues  4

Acidic residues  1

Hydrophobic residues  8

Net charge  3

Boman Index  -1440

Hydrophobicity  -3.18

Aliphatic Index  110.91

Half Life 
  Mammalian: 1.4 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18307172

Title  Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines

Doi 10.1002/jcb.21712

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.